Radiopharmaceuticals in Nuclear Medicine Comprehensive Study by Type (Diagnostic Nuclear Medicine (PECT Radiopharmaceuticals, PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters), Brachytherapy Isotopes (Iodine-125, Palladium-103, Cesium-131, Iridium-192, Other)), Application (SPECT Applications (Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications), PET Applications (Oncology, Cardiology, Neurology, Other PET Applications), Therapeutic Applications (Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other)), End User (Hospitals, Research Institutes, Others) Players and Region - Global Market Outlook to 2026

{reportSlug=global-radiopharmaceuticals-in-nuclear-medicine-market, reportId=50239, mktKeyword=Radiopharmaceuticals in Nuclear Medicine, cagr=0.00, publishDate=Nov 2021, priceOption2=7500, reportTitle=Radiopharmaceuticals in Nuclear Medicine Comprehensive Study by Type (Diagnostic Nuclear Medicine (PECT Radiopharmaceuticals, PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters), Brachytherapy Isotopes (Iodine-125, Palladium-103, Cesium-131, Iridium-192, Other)), Application (SPECT Applications (Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications), PET Applications (Oncology, Cardiology, Neurology, Other PET Applications), Therapeutic Applications (Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other)), End User (Hospitals, Research Institutes, Others) Players and Region - Global Market Outlook to 2026, baseYr=2021, totalTableFig=200, priceOption1=3750, forecastYr=2027, noOfPages=208, reportKey=49933, breadcrum=Global Radiopharmaceuticals in Nuclear Medicine}